Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis - Wikidata - wikimedia - TriplyDB

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

http://www.wikidata.org/entity/Q34186473

about

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).Reflections on Lupus 2013: butterflies, wolves and prophecies.Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon.Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features Anti-HMGCR antibodies in systemic sclerosis Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.Isolated Ro52 Antibodies as Immunological Marker of a Mild Phenotype of Undifferentiated Connective Tissue Diseases.Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis.The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review.Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis.A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.Novel insights into systemic autoimmune rheumatic diseases using shared molecular signatures and an integrative analysis.Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay.Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis?Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus

P2860

Q33737250-33DA0A31-2A2E-48EE-BEBB-EF98263E8AA7 Q34976836-BB9B163D-B33F-49B3-95DC-0B484A433D79 Q35668003-C26912CF-708B-4104-B3DA-E7DF203F7B64 Q35731532-BE82F55E-A7EE-420E-99E3-49A7747EDFF9 Q36150826-264E7323-194B-4636-B263-6959ED4D1A0E Q36196309-C07213DB-4465-4AAB-9D3B-9FAD537F2577 Q37226360-ECC8FA6C-32EE-43C6-8D4B-84A0BC489EF7 Q37624918-245C01EF-AB61-498D-96CB-3450E0623991 Q37690559-6915A462-A694-4CCF-BF09-3F597F0224D0 Q38139286-735C3565-0227-40C3-916A-4D53A3B25BAB Q38888863-C796F2A7-FB33-43D1-806B-8CE9BB505816 Q39247284-12EE9D9D-E2C5-40BD-AAF1-B1C0BF27AE42 Q40176801-609E8A01-12ED-4C80-BD4E-832E90D2B5DC Q40253467-B4E2D0DB-A76A-4975-8A61-623F631D8ECE Q40291320-6A23913D-9177-4044-BB7C-1520DFC0E96B Q40593651-AF42B1A1-BA3C-41D9-BEF8-D3B7EBA01117 Q40656308-8F5447B9-3D57-4966-8041-6AE68111CFAA Q40891723-3FE24645-6DF1-4268-B5C0-7D876F67B4B3 Q41532980-6CFA7F7B-93A5-404F-8D5F-0DFBFCE04BC5 Q45357250-8D656706-BDE9-4E83-B059-D3C232B53671 Q54248023-2B7C7233-0D3F-4E5F-B578-B4E9E440D0C1 Q59034615-F9DD948F-56AD-40E4-937C-905CDC345C74

P2860

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

http://www.wikidata.org/entity/Q34186473

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@ast

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@en

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@nl

type

label

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@ast

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@en

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@nl

prefLabel

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@ast

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@en

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@nl

P1433

Q34186473-3B53C064-D4A0-43DB-8EE4-A6DA20AE83BD

P1476

Q34186473-D4B124E2-44D7-480F-AB9A-78567F8749CB

P2093

Q34186473-29DBCEAE-B782-4DC4-805E-20CC41E92E5A

Q34186473-45A65432-F797-4B0E-B6CA-3C37D72B5A04

Q34186473-98AB3910-FAF2-4427-90CB-11B88E31358C

Q34186473-CD0B3202-9849-4EE8-BB0E-8BCCC29C469C

Q34186473-DAC017D6-4A6F-46D2-A1CB-6135A2A301A5

P2860

Q34186473-02350A3E-0AAF-47C9-AFD6-7AA84384764F

Q34186473-064AC41B-3032-4845-9C60-CC3B29A8E741

Q34186473-1FFA62F5-FB3B-49DB-818B-F3FEF7B51F6C

Q34186473-3528E24E-B240-41A3-B9A9-831C9131B533

Q34186473-3A9187C4-72E9-4771-A92D-EA721F358B45

Q34186473-3F58A1EF-E747-4421-8E35-788E6D990F62

Q34186473-411B2771-CD93-46B9-8980-E8427980A39D

Q34186473-4848BC40-32B1-4C34-9C28-7659686FB5B9

Q34186473-4DECB58E-EF9C-4328-97CF-FD7C65466F80

Q34186473-4E81F562-6071-4B6B-93BC-437920C4EF90

P2888

Q34186473-7D4E9290-8FA5-47E5-A870-4CD8341FA45A

P304

Q34186473-3EBAD87F-332D-44D2-A35B-50F63C9B420D

P31

Q34186473-922BC6B2-8F53-4A14-AF1B-32515C2B2B99

P356

Q34186473-B7CABB14-8505-4513-B7D5-B1B547CDB523

P433

Q34186473-6824A51C-0B87-4C36-82DF-EE83DFDCEF84

P478

Q34186473-FFED87D8-12DE-4BAB-B077-FDD4B1E2AC6C

P50

Q34186473-110B98CD-3D1A-4D5A-A5EA-B2378FCB0DA5

Q34186473-1323FC1F-C685-4BF0-B1A9-1147EF0C163C

Q34186473-2F2C02C9-ADD9-4BA2-A6E8-572B0E247DEB

P577

Q34186473-AE0912B7-F8BF-468E-AE49-4944CB9E8C4B

P5875

Q34186473-3622C00A-3C40-444C-8693-255D39AB9480

P6179

Q34186473-94439E9F-4A97-48BE-867D-309CDCA76016

P698

Q34186473-4004FC62-951A-47D5-A1AF-A9E0A20F703D

P921

Q34186473-B3F269AF-61A3-4E61-B828-A03D28C32C0A

P932

Q34186473-49472EF9-665F-4190-A1EF-A353C116BE6C

P356

P1433

Arthritis Research and Therapy

P1476

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

@en

P2093

Janet Pope

http://www.w3.org/2001/XMLSchema#string

Marie Hudson

http://www.w3.org/2001/XMLSchema#string

Murray Baron

http://www.w3.org/2001/XMLSchema#string

Russell Steele

http://www.w3.org/2001/XMLSchema#string

Solène Tatibouet

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibodies directed to novel components of the PM/Scl complex, the human exosome

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights

Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.

Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts

The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.

Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.

Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon production

P2888

P304

R50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3763

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Marvin J Fritzler

Canadian Scleroderma Research Group (CSRG)

P577

2012-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221681528

http://www.w3.org/2001/XMLSchema#string

P6179

1052090456

http://www.w3.org/2001/XMLSchema#string

P698

22394602

http://www.w3.org/2001/XMLSchema#string

P921

P932

3446416

http://www.w3.org/2001/XMLSchema#string